Page last updated: 2024-08-17

trifluridine and cmx 001

trifluridine has been researched along with cmx 001 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Akhtar, N; Al-Tammemi, AB; Al-Tawfiq, JA; Chatterjee, C; Chattu, VK; Dwivedi, P; Mohanty, A; Nowrouzi-Kia, B; Padhi, BK; Pradhan, A; Rodriguez-Morales, AJ; Sah, R; Satapathy, P; Shamim, MA; Tripathy, S; Veeramachaneni, SD1
Akazawa, D; Azam, AH; Ebihara, H; Hishiki, T; Kataoka, M; Kawahara, M; Kiga, K; Maeda, K; Mifune, J; Morita, T; Nakajima, S; Ohashi, H; Ojima, S; Park, ES; Shimojima, M; Shionoya, K; Suzuki, T; Takahashi, Y; Tsuchimoto, K; Watashi, K; Yoshikawa, T1

Reviews

1 review(s) available for trifluridine and cmx 001

ArticleYear
The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2023, Volume: 127

    Topics: Antiviral Agents; Benzamides; Cidofovir; Disease Outbreaks; Humans; Isoindoles; Monkeypox virus; Mpox (monkeypox); Trifluridine

2023

Other Studies

2 other study(ies) available for trifluridine and cmx 001

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Identification of IMP Dehydrogenase as a Potential Target for Anti-Mpox Virus Agents.
    Microbiology spectrum, 2023, 08-17, Volume: 11, Issue:4

    Topics: Guanosine; IMP Dehydrogenase; Monkeypox virus; Mycophenolic Acid; Trifluridine

2023